Sunday, February 23, 2025
HomeTagsOncology

Oncology

Lantern Pharma’s Proprietary A.I. Platform for Precision Oncology Drug Development, RADR®, Surpasses 10 Billion Datapoints

Lantern Pharma (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("A.I.") platform to transform the cost, pace, and timeline...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics